[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Neisseria Gonorrhoeae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 SUMMARY Neonatal Respiratory Distress Syndrome (Respiratory) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Nerve Injury (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Nerve Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Nerve Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Nerve Injury pipeline landscap...

April 2021 30 pages

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) (Genetic Disorders) - Dru...

April 2021 40 pages

Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Neuroendocrine Cancer pipeline landscape...

April 2021 45 pages

Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Neuroendocrine Carcinoma pipeline...

April 2021 40 pages

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021 SUMMARY Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) (Oncology) - Drugs in Development, 2021 pr...

April 2021 55 pages

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021

 US$ 3,000.00

Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021 SUMMARY Neurogenic Locus Notch Homolog Protein 1 (Translocation Associate...

April 2021 35 pages

Neuroinflammation (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Neuroinflammation (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuroinflammation (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuroinflammation pi...

April 2021 90 pages

Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021

 US$ 3,000.00

Neuromedin K Receptor (NK3 Receptor or Neurokinin B Receptor or Tachykinin Receptor 3 or NK3R or TACR3) - Drugs in Development, 2021 SUMMARY Neuromedin K Receptor (NK3 Receptor or Neurokinin B Recepto...

April 2021 30 pages

Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuromuscular Disorders (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuromus...

April 2021 55 pages

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021

 US$ 3,000.00

Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021 provides in depth an...

April 2021 30 pages

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021

 US$ 3,000.00

Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021 SUMMARY Neuronal Acetylcholine Receptor Subunit Beta 4 (CHRNB4) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,500.00

Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuropathic Pain (Neuralgia) (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 325 pages

Neuropathy (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Neuropathy (Central Nervous System) - Drugs in Development, 2021 SUMMARY Neuropathy (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Neuropathy pipeline landscape. The...

April 2021 35 pages

Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021

 US$ 3,000.00

Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or NRP1) - Drugs in Development, 2021 SUMMARY Neuropilin 1 (Vascular Endothelial Cell Growth Factor 165 Receptor or CD304 or...

April 2021 30 pages

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021

 US$ 3,000.00

Neurotensin Receptor Type 1 (NTR1 or High Affinity Levocabastine Insensitive Neurotensin Receptor or NTRH or NTSR1) - Drugs in Development, 2021 SUMMARY Neurotensin Receptor Type 1 (NTR1 or High Affin...

April 2021 30 pages

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021

 US$ 3,000.00

Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021 SUMMARY Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021 provides in depth analysis...

April 2021 35 pages

Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021 SUMMARY Nicotine Addiction (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Nicotine Addiction...

April 2021 65 pages

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021

 US$ 3,000.00

Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Like Pro...

April 2021 35 pages

Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021

 US$ 3,000.00

Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 SUMMARY Niemann Pick C1 Protein (NPC1) - Drugs in Development, 2021 provides in depth analysis on Niemann Pick C1 Protein (NPC1) targeted pi...

April 2021 30 pages

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021

 US$ 3,000.00

Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021 SUMMARY Nitric Oxide Synthase (NO Synthase or NOS or EC 1.14.13.39) - Drugs in Development, 2021 provides in de...

April 2021 35 pages

Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Nodal Marginal Zone B-Cell Lymphoma (Oncology) - Drugs in Development, 2021 provides an overview of the Nodal Margin...

April 2021 50 pages

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) (Oncolog...

April 2021 115 pages

Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Non-Proliferative Diabetic Retinopathy (NPDR) (Metabolic Disorders) - Drugs in Development, 202...

April 2021 35 pages

Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Non-Small Cell Lung Carc...

April 2021 110 pages

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Nonerosive Reflux Disease (NERD) (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the No...

April 2021 30 pages

Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021 provides...

April 2021 30 pages

Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Nonmelanomatous Skin Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Nonmelanomatous Skin Cancer...

April 2021 35 pages

Nonstructural Protein 1 (NS1) - Drugs in Development, 2021

 US$ 3,000.00

Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 1 (NS1) targeted pipel...

April 2021 35 pages

Nonstructural Protein 3 (NS3) - Drugs in Development, 2021

 US$ 3,000.00

Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 3 (NS3) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 3 (NS3) targeted pipel...

April 2021 30 pages

Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021

 US$ 3,000.00

Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 4B (NS4B) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 4B (NS4B) targeted...

April 2021 30 pages

Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021

 US$ 3,000.00

Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 SUMMARY Nonstructural Protein 5A (NS5A) - Drugs in Development, 2021 provides in depth analysis on Nonstructural Protein 5A (NS5A) targeted...

April 2021 60 pages

Norovirus Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Norovirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Norovirus Infections p...

April 2021 50 pages

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021

 US$ 3,000.00

NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021 SUMMARY NS5B (Nonstructural Protein 5B Polymerase or EC 2.7.7.48) - Drugs in Development, 2021 provides in depth...

April 2021 55 pages

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021

 US$ 3,000.00

Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021 SUMMARY Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6)...

April 2021 35 pages

Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021 SUMMARY Obstructive Sleep Apnea (Respiratory) - Drugs in Development, 2021 provides an overview of the Obstructive Sleep Apnea pipeli...

April 2021 55 pages

Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 SUMMARY Ocular Inflammation (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Ocular Inflammation pipeline lands...

April 2021 85 pages

Ocular Melanoma (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Ocular Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Ocular Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ocular Melanoma pipeline landscape. The report provi...

April 2021 40 pages

Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Ocular Pain (Eye Pain) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Ocular Pai...

April 2021 55 pages

Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Onchocerciasis (River Blindness) (Infectious Disease) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021 SUMMARY Open-Angle Glaucoma (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Open-Angle Glaucoma pipeline lands...

April 2021 85 pages

Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021 SUMMARY Opioid Induced Side Effects (Oncology) - Drugs in Development, 2021 provides an overview of the Opioid Induced Side Effects...

April 2021 30 pages

Opioid Receptor (OPR) - Drugs in Development, 2021

 US$ 3,000.00

Opioid Receptor (OPR) - Drugs in Development, 2021 SUMMARY Opioid Receptor (OPR) - Drugs in Development, 2021 provides in depth analysis on Opioid Receptor (OPR) targeted pipeline therapeutics. The re...

April 2021 40 pages

Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Opium Withdrawal Syndrome (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Opiu...

April 2021 35 pages

Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021

 US$ 2,000.00

Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021 SUMMARY Optic Nerve Injury (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Optic Nerve Injury pipeline landscap...

April 2021 35 pages

Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Oral Cavity (Mouth) Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Oral Cavity (Mouth) Cancer pip...

April 2021 75 pages

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021

 US$ 3,000.00

Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021 SUMMARY Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamy...

April 2021 35 pages

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021

 US$ 3,000.00

Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021 SUMMARY Ornithine Decarboxylase (ODC or ODC1 or EC 4.1.1.17) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 35 pages

Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Oropharyngeal Candidiasis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Oropharyngea...

April 2021 30 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1